Replies to post #6819 on Vericel Corp. (VCEL)

[lasers]

ICT and the Chinese hgov't ad already made that decision in the positive as of May 2017 license agreement. ICT will know exactly what the ethnic background and gender is of all the 114 participants and every previous Ixcell DCM trials for Phase 1 and Phase 2A that have led to Phase2B. ICT had already planned to Manufacture and Market Ixcell DCM BLA. With the FDA decision in Sept 2017 of a Phase 3 required, there is no doubt whatsoevr IMO that the Chinese gov't made the decision and announcement of today Oct 9, 2017

[lasers]

north40000 It is important to note that $VCEL Ixcell DCM is an autologous BLA so that the donor's DNAs from their bone marrow and the host's DNAs are from the exact same person and therefore $VCEL's Ixcell DCM BLA will be compatible anywhere with all ethnic populations in the globe.